Treatment | Page 10 of 465 | SpiritIndia.com

Hepatitis C :: 24-week course of interferon-alpha therapy prolongs survival in patients hepatitis C virus

Patients with the hepatitis C virus (HCV) have a risk of frequent recurrence and deterioration of liver function, even after curative treatment for the primary hepatocellular carcinoma (HCC). This unfavorable prognosis is associated with a sustained HCV infection. Thus, both the prevention of HCC recurrence and the preservation of liver function are high priorities when trying to improve the prognosis of patients with HCV-related HCC. Antiviral therapy for chronic hepatitis C (HCV) after treatment for primary HCC is the essential factor required for an improved prognosis.

Prostate Cancer :: Men, don’t skip your prostate cancer treatment appointments!

Men with “low risk” prostate cancer who miss more than two radiation treatments in an eight week treatment face an increased chance of their cancer recurring. That is the conclusion of a new study examining more than 15 years of data and nearly 1,800 patients treated at Fox Chase Cancer Center in Philadelphia. The results were presented today at the American Society for Therapeutic Radiology and Oncology’s 49th Annual Meeting in Los Angeles.

HIV :: HIV-TB spreads in Africa, undermines control of world’s 2 deadliest infectious diseases

The largely unnoticed collision of the global epidemics of HIV and tuberculosis (TB) has exploded to create a deadly co-epidemic that is rapidly spreading in sub-Saharan Africa. However, health systems cannot adequately diagnose, treat, or contain the co-epidemic due to unanswered scientific and medical questions, according to a report issued today by The Forum for Collaborative HIV Research and amplified by experts from leading global health organizations.

Health Care :: Survey finds one-third of US adults call for completely rebuilding the health care system

At a time when the U.S. spends more than double what other countries spend for medical care—$6,697 per capita in 2005—a new Commonwealth Fund seven-nation survey finds that U.S. patients are more likely to report experiencing medical errors, to go without care because of costs, and to say that the health care system needs to be rebuilt completely.

Liver Cancer :: Radio waves fire up nanotubes embedded in tumors, destroying liver cancer

Cancer cells treated with carbon nanotubes can be destroyed by non-invasive radio waves that heat up the nanotubes while sparing untreated tissue, a research team led by scientists at The University of Texas M. D. Anderson Cancer Center and Rice University has shown in preclinical experiments.

Prostate Cancer :: Radiation seed implant decreases risk of death over watchful waiting

Prostate cancer patients cut their risk of dying of the disease in half when they receive radiation seed implants (brachytherapy) to treat their cancer, compared to those who don’t receive active treatment (watchful waiting/active surveillance), within six months from being diagnosed with localized prostate cancer, according to a study presented October 31, 2007, at the American Society for Therapeutic Radiology and Oncology’s 49th Annual Meeting in Los Angeles.

Pregnancy :: Caesarean births pose higher risks for mother and baby

Women having a non-emergency caesarean birth have double the risk of illness or even death compared to a vaginal birth, according to a study from Latin America published today on bmj.com.

Prostate Cancer :: Radiation after surgery keeps high-risk prostate cancer at bay

An analysis of data involving more than 2,000 patients from 17 U.S. institutions demonstrates that men with high-risk prostate cancer who receive radiation therapy after a prostatectomy were less likely to have a recurrence of disease. What’s more, men whose cancer persists after surgery were less likely to see the cancer spread if they receive radiation (salvage therapy). These are the conclusions of a study presented today at the American Society for Therapeutic Radiology and Oncology’s 49th Annual Meeting in Los Angeles.

Stem Cell :: Jefferson researchers find stem cells in degenerating spinal discs, potential for repair

Orthopedic researchers at Jefferson Medical College have for the first time found stem cells in the intervertebral discs of the human spine, suggesting that such cells might someday be used to help repair degenerating discs and remedy lower back and neck pain.

Ovarian Cancer :: Novel medication improves ovarian cancer treatment

A new study appearing in International Journal of Gynecological Cancer states that Bevacizumab, a biologic anti-cancer agent that prevents tumor growth by interfering with the formation of new blood vessels, may have the potential to improve the efficacy of standard combination chemotherapy in ovarian cancer.